MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques

被引：103

作者：

Wang, Chong ^{[1
,2
]}

Zheng, Xuexing ^{[2
,3
,4
]}

Gai, Weiwei ^{[2
]}

Zhao, Yongkun ^{[2
,4
]}

Wang, Hualei ^{[2
,4
]}

Wang, Haijun ^{[2
]}

Feng, Na ^{[2
,4
]}

Chi, Hang ^{[2
]}

Qiu, Boning ^{[2
]}

Li, Nan ^{[2
]}

Wang, Tiecheng ^{[2
,4
]}

Gao, Yuwei ^{[2
,4
]}

Yang, Songtao ^{[2
,4
]}

Xia, Xianzhu ^{[2
,4
]}

机构：

[1] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China

[2] Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Peoples R China

[3] Shandong Univ, Sch Publ Hlth, Jinan, Peoples R China

[4] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China

来源：

ONCOTARGET | 2017年 / 8卷 / 08期

关键词：

Middle East respiratory syndrome coronavirus; vaccine; virus-like particles; nonhuman primates; immune response; EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; SYNDROME CORONAVIRUS; NEUTRALIZING ANTIBODIES; SPIKE PROTEIN; VACCINE DEVELOPMENT; MOUSE MODEL; INFECTION; EFFICACY; SYSTEMS;

D O I：

10.18632/oncotarget.8475

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease in humans with a case fatality rate of over 39%, and poses a considerable threat to public health. A lack of approved vaccine or drugs currently constitutes a roadblock in controlling disease outbreak and spread. In this study, we generated MERS-CoV VLPs using the baculovirus expression system. Electron microscopy and immunoelectron microscopy results demonstrate that MERS-CoV VLPs are structurally similar to the native virus. Rhesus macaques inoculated with MERS-CoV VLPs and Alum adjuvant induced virus-neutralizing antibodies titers up to 1: 40 and induced specific IgG antibodies against the receptor binding domain (RBD), with endpoint titers reaching 1:1,280. MERS-CoV VLPs also elicited T-helper 1 cell (Th1)-mediated immunity, as measured by ELISpot. These data demonstrate that MERS-CoV VLPs have excellent immunogenicity in rhesus macaques, and represent a promising vaccine candidate.

引用

页码：12686 / 12694

页数：9

共 29 条

[1] Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate [J].

Almazan, Fernando ;

DeDiego, Marta L. ;

Sola, Isabel ;

Zuniga, Sonia ;

Nieto-Torres, Jose L. ;

Marquez-Jurado, Silvia ;

Andres, German ;

Enjuanes, Luis .

MBIO, 2013, 4 (05)

[2] Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection [J].

Arabi, Yaseen M. ;

Arifi, Ahmed A. ;

Balkhy, Hanan H. ;

Najm, Hani ;

Aldawood, Abdulaziz S. ;

Ghabashi, Alaa ;

Hawa, Hassan ;

Alothman, Adel ;

Khaldi, Abdulaziz ;

Al Raiy, Basel .

ANNALS OF INTERNAL MEDICINE, 2014, 160 (06) :389-+

[3] A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response [J].

Bolles, Meagan ;

Deming, Damon ;

Long, Kristin ;

Agnihothram, Sudhakar ;

Whitmore, Alan ;

Ferris, Martin ;

Funkhouser, William ;

Gralinski, Lisa ;

Totura, Allison ;

Heise, Mark ;

Baric, Ralph S. .

JOURNAL OF VIROLOGY, 2011, 85 (23) :12201-12215

[4] Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process [J].

Buckland, Barry ;

Boulanger, Robert ;

Fino, Mireli ;

Srivastava, Indresh ;

Holtz, Kathy ;

Khramtsov, Nikolai ;

McPherson, Clifton ;

Meghrous, Jamal ;

Kubera, Paul ;

Cox, Manon M. J. .

VACCINE, 2014, 32 (42) :5496-5502

[5] Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice [J].

Coleman, Christopher M. ;

Liu, Ye V. ;

Mu, Haiyan ;

Taylor, Justin K. ;

Massare, Michael ;

Flyer, David C. ;

Glenn, Gregory M. ;

Smith, Gale E. ;

Frieman, Matthew B. .

VACCINE, 2014, 32 (26) :3169-3174

[6] Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015 [J].

Cowling, B. J. ;

Park, M. ;

Fang, V. J. ;

Wu, P. ;

Leung, G. M. ;

Wu, J. T. .

EUROSURVEILLANCE, 2015, 20 (25) :7-13

[7] Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques [J].

de Wit, Emmie ;

Rasmussen, Angela L. ;

Falzarano, Darryl ;

Bushmaker, Trenton ;

Feldmann, Friederike ;

Brining, Douglas L. ;

Fischer, Elizabeth R. ;

Martellaro, Cynthia ;

Okumura, Atsushi ;

Chang, Jean ;

Scott, Dana ;

Benecke, Arndt G. ;

Katze, Michael G. ;

Feldmann, Heinz ;

Munster, Vincent J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (41) :16598-16603

[8] Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development [J].

Du, Lanying ;

Zhao, Guangyu ;

Kou, Zhihua ;

Ma, Cuiqing ;

Sun, Shihui ;

Poon, Vincent K. M. ;

Lu, Lu ;

Wang, Lili ;

Debnath, Asim K. ;

Zheng, Bo-Jian ;

Zhou, Yusen ;

Jiang, Shibo .

JOURNAL OF VIROLOGY, 2013, 87 (17) :9939-9942

[9] A decade after SARS: strategies for controlling emerging coronaviruses [J].

Graham, Rachel L. ;

Donaldson, Eric F. ;

Baric, Ralph S. .

NATURE REVIEWS MICROBIOLOGY, 2013, 11 (12) :836-848

[10] Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission [J].

Guery, Benoit ;

Poissy, Julien ;

el Mansouf, Loubna ;

Sejourne, Caroline ;

Ettahar, Nicolas ;

Lemaire, Xavier ;

Vuotto, Fanny ;

Goffard, Anne ;

Behillil, Sylvie ;

Enouf, Vincent ;

Caro, Valerie ;

Mailles, Alexandra ;

Che, Didier ;

Manuguerra, Jean-Claude ;

Mathieu, Daniel ;

Fontanet, Arnaud ;

van der Werf, Sylvie .

LANCET, 2013, 381 (9885) :2265-2272

← 1 2 3 →